Haemophilia A

Haemophilia A is a genetic disorder characterised by defficiency of Factor VIII in the blood. The factor VIII gene is located on the X chromosome . Thus this disorder is a sex linked disorder.

  • One in 10,000 males is born with deficiency or dysfunction of the factor VIII molecule.
  • Although normal hemostasis requires at least 25 percent factor VIII activity, symptomatic patients usually have factor VIII levels below 5 percent.
  • Patients with <1 percent factor VIII activity have severe disease.
  • Patients with levels between 1 and 5 percent have moderatedisease with less frequent bleeding episodes.
  • Those with levels over 5 percent have mild disease with infrequent bleeding that is usually secondary to trauma.
  • Occasional patients with factor VIII levels as high as 25 percent are discovered when they bleed after major trauma or surgery.
  • The majority of patients with Haemophilia A have factor VIII below 5 %
  • All daughters of haemophilics are carriers and sisters have a 50 % chance of being a carrier.
  • If a carrier has a son he has 50 % chance of having haemophilia, and a daughter has 50 % chance of of being a carrier.
  • Haemophilia ‘breeds true’ within a family. All members of a family will have same abnormality of factor VIII gene, i.e. if one member has severe form of the disease all other affected would have severe form of the disease.
  • In carrriers of this disease, Ratio of factor VIIIC : von Willibrand factor (vWF) is reduced compared to the normal.
  • Tracing of the haemophilia gene within families can be done using gene probes which detect restriction fragment length polymorphism (RFLPs).
  • Antenatal diagnosis can be done in females having high degree of probability of being a carrier. This is done by doing chorion villus sampling at 8-9 weeks of gestation.

Haemophilia B

Hemophilia B is similar to Hemophilia A. Both are abnormality of blood coagulation. Hemophilia B is caused by the deficiency of Factor IX. It is also known as Christmas disease. It occurs in 1 in 100,000 male births. It has to be diagnosed accurately because clinically it is indistinguishable from factor VIII deficiency – Hemophilia A.

Factor IX is one of a group of six proteins synthesized in the liver that require vitamin K for biologic activity.

Treatment of Haemophilia A

Plasma products enriched in factor VIII have revolutionized the care of hemophilia patients, reduced the degree of orthopedic deformity, and permitted virtually any form of elective and emergency surgery. Now this mode of treatment is being widely used.

The widespread use of factor VIII concentrates also has produced some serious complications, including viral hepatitis, chronic liver disease, and AIDS.

Cryoprecipitate, which contains about half the factor VIII activity of fresh frozen plasma in one-tenth the original volume, is simple to prepare and is produced in hospital or regional blood banks. It must be stored frozen and is thawed and pooled before administration. Partially purified factor VIII concentrate, which is prepared from multiple donors and supplied as a lyophilized powder, can be refrigerated and reconstituted just before use.

There had been immense problem with the safety of these products. Three major developments have increased the safety of factor VIII therapy. First, heating of lyophilized factor VIII concentrates under carefully controlled conditions can inactivate human immunodeficiency virus (HIV) without destroying factor VIII coagulant activity. Second, highly purified factor VIII can be produced by adsorbing and eluting factor VIII from monoclonal antibody columns. Third, recombinant factor VIII is now available.

Patients with hemophilia should receive either monoclonal purified or recombinant factor VIII to minimize viral infections and other complications.

It has been determined empirically that each unit of factor VIII infused, defined as the amount present in 1 ml normal plasma, will raise the plasma level of the recipient by 2 percent per kilogram of body weight. Factor VIII has a half-life of 8 to 12 h, making it necessary to infuse it continuously or at least twice daily to sustain a chosen factor VIII level. In patients with mild hemophilia, an alternative to the use of plasma products is desmopressin (DDAVP), which transiently increases the factor VIII level. Desmopressin, in general, will increase the factor level two- to threefold. Although generally safe, it occasionally causes hyponatremia or may precipitate thrombosis in elderly patients.

  • An uncomplicated episode of soft tissue bleeding or an early bleeding into a joint can be treated with one infusion of sufficient factor VIII concentrate to raise the factor VIII level to 15 or 20 percent. A more extensive  bleeding requires twice-daily or continuous infusions in order to keep the factor VIII level between 25 and 50 percent for at least 72 h. Life-threatening bleeding into the central nervous system or major surgery may require therapy for 2 weeks with levels kept at a minimum of 50 percent of normal.
  • Patients with joint involvement also need skilled orthopedic care with immobilization of inflamed joints to promote healing and to prevent contractures and physical therapy to strengthen muscles and maintain joint mobility.
  • Hemophiliacs also require treatment before dental procedures. Filling of a carious tooth can be managed by a single infusion of cryoprecipitate or factor VIII concentrate coupled with the administration of 4 to 6 g of e-aminocaproic acid (EACA) four times daily for 72 to 96 h after the dental procedure. EACA is a potent antifibrinolytic agent that will inhibit plasminogen activators present in oral secretions and stabilize clot formation in oral tissue.

Most hemophiliac patients have had multiple episodes of hepatitis, and a majority have elevated hepatocellular enzyme levels and abnormalities on liver biopsy. Between 10 and 20 percent of patients also have hepatosplenomegaly, and a small number develop chronic active or persistent hepatitis or cirrhosis. A few patients with hemophilia have received liver transplants with cure of both diseases.

Following multiple transfusions, between 10 and 20 percent of patients with severe hemophilia develop inhibitors to factor VIII. Inhibitors are, generally, IgG antibodies that rapidly neutralize factor VIII activity. Before surgery, every patient should be screened for the presence of an inhibitor to factor VIII.

Female carriers of hemophilia, who are heterozygotes, usually produce sufficient factor VIII from the factor VIII allele on their normal X chromosome for normal hemostasis. However, occasional hemophilia carriers will have factor VIII levels far below 50 percent due to random inactivation of normal X chromosomes in tissue producing factor VIII. These symptomatic carriers may bleed with major surgery or bleed occasionally with menses. Rarely, true female hemophiliacs arise from consanguinity within families with hemophilia or from concomitant Turner’s syndrome or XO mosaicism in a carrier female.

This entry was posted in Diseases & Conditions, Genetics and tagged by Manbir & Gurpreet. Bookmark the permalink.

About Manbir & Gurpreet

Gurpreet Kaur’s journey in this world .... Gurpreet Kaur was a Musician. She was a singer and a composer of music. Her interest was composing and singing Gurbani Shabads in Indian Classical style. She sang Shabads in All the Raags mentioned in Sri Guru Granth Sahib Ji. She also taught Gurmat Sangeet at Gurmat Gian Missionary College, Jawadi, Ludhiana. Elder child to Pushpinder Kaur and Dr. Brig. Harminder Singh, was born in Amritsar on 13th Jan 1962. She attended various convent schools as a child because her father would get frequent Army postings as a dental surgeon. She graduated with Music Honors from Govt. College for Women, Chandigarh. Music was her hobby and she composed and sang Raag based Gurbani Shabads. Doing Kirtan was part of growing up nurtured by her parents. She learned music from her father Dr. Brigadier Harminder Singh who was a dental surgeon in Indian Army and a very good singer himself. Gurpreet’s Bhua (father’s sister), Ajit Kaur retied as a Head of Department of Music from Govt. College for Women Ludhiana, and was a renounced Punjabi singer of her time. Gurpreet Kaur also learned nuances of Indian Classical Music from Pandita Sharma. She was a mother of three children, and a grandmother. Her daughter Keerat Kaur is a Computer Engineer. Her two sons Gurkeerat Singh and Jaskeerat Singh are doctors in USA. Her daughter Keerat Kaur too was part of her group ~ Gurmat Gian Group. Gurpreet Kaur left this world at the age of 54yrs on 12th Sept 2016 in Baltimore USA. She had recorded around 25 cds of Gurbani Keertan. 'Raag Ratan' Album (6 CDs) is a Compilation of Shabads in All the 31 Sudh Raags of Sri Guru Granth Sahib Ji. 'Gauri Sagar' Album (3 CDs) is a Compilation of All forms of Raag Gauri in Sri Guru Granth Sahib Ji. 'Nanak Ki Malhaar' ~ ((3 CDs) is an album of Raag Malhar Shabads in various forms of Malhar. 'Gur Parsaad Basant Bana' ~ (3 CDs) is an album of Shabads in Raag Basant sung in various forms of Raag Basant. Har Ki Vadeyai Sarni Aayea Sewa Priya Kee Preet Piyaree Mohan Ghar Aavho Karo Jodariya Mo Kao Taar Le Raama Taar Le Tere Kavan Kavan Gun Keh Keh Gawan Mera Baid Guru Govinda Saajanrraa Mera Saajanrraa

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s